182 related articles for article (PubMed ID: 11313903)
1. Autocrine and paracrine signaling through neuropeptide receptors in human cancer.
Heasley LE
Oncogene; 2001 Mar; 20(13):1563-9. PubMed ID: 11313903
[TBL] [Abstract][Full Text] [Related]
2. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
3. A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro.
Woll PJ; Rozengurt E
Cancer Res; 1990 Jul; 50(13):3968-73. PubMed ID: 1693879
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.
Ryder NM; Guha S; Hines OJ; Reber HA; Rozengurt E
J Cell Physiol; 2001 Jan; 186(1):53-64. PubMed ID: 11147814
[TBL] [Abstract][Full Text] [Related]
5. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
Langdon S; Sethi T; Ritchie A; Muir M; Smyth J; Rozengurt E
Cancer Res; 1992 Aug; 52(16):4554-7. PubMed ID: 1379515
[TBL] [Abstract][Full Text] [Related]
6. Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides.
Gudermann T; Roelle S
Endocr Relat Cancer; 2006 Dec; 13(4):1069-84. PubMed ID: 17158754
[TBL] [Abstract][Full Text] [Related]
7. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo.
Sethi T; Langdon S; Smyth J; Rozengurt E
Cancer Res; 1992 May; 52(9 Suppl):2737s-2742s. PubMed ID: 1314136
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal peptide signalling in health and disease.
Rozengurt E; Guha S; Sinnett-Smith J
Eur J Surg Suppl; 2002; (587):23-38. PubMed ID: 16144198
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.
Péqueux C; Keegan BP; Hagelstein MT; Geenen V; Legros JJ; North WG
Endocr Relat Cancer; 2004 Dec; 11(4):871-85. PubMed ID: 15613460
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin (CCK) and CCK receptor expression by human gliomas: Evidence for an autocrine/paracrine stimulatory loop.
Oikonomou E; Buchfelder M; Adams EF
Neuropeptides; 2008 Jun; 42(3):255-65. PubMed ID: 18423848
[TBL] [Abstract][Full Text] [Related]
14. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of gastrin-CCKB receptor promotes migration of gastric AGS cells via multiple paracrine pathways.
Noble PJ; Wilde G; White MR; Pennington SR; Dockray GJ; Varro A
Am J Physiol Gastrointest Liver Physiol; 2003 Jan; 284(1):G75-84. PubMed ID: 12488236
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of neuropeptide Y receptors in human neuroblastoma cells.
Li AJ; Ritter S
Regul Pept; 2005 Jul; 129(1-3):119-24. PubMed ID: 15927706
[TBL] [Abstract][Full Text] [Related]
17. Peptide hormones and lung cancer.
Moody TW
Panminerva Med; 2006 Mar; 48(1):19-26. PubMed ID: 16633328
[TBL] [Abstract][Full Text] [Related]
18. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
Guha S; Eibl G; Kisfalvi K; Fan RS; Burdick M; Reber H; Hines OJ; Strieter R; Rozengurt E
Cancer Res; 2005 Apr; 65(7):2738-45. PubMed ID: 15805273
[TBL] [Abstract][Full Text] [Related]
19. The role of fibroblast growth factors and their receptors in prostate cancer.
Kwabi-Addo B; Ozen M; Ittmann M
Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
[TBL] [Abstract][Full Text] [Related]
20. Autocrine, paracrine and juxtacrine signaling by EGFR ligands.
Singh AB; Harris RC
Cell Signal; 2005 Oct; 17(10):1183-93. PubMed ID: 15982853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
